Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.
about
Sphingosine kinase 1 isoform-specific interactions in breast cancerMammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease."Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.
P2860
Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@ast
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@en
type
label
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@ast
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@en
prefLabel
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@ast
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@en
P2860
P921
P356
P1476
Switching the sphingolipid rhe ...... rom a problem to an advantage.
@en
P2093
Eileen M McGowan
Najah Nassif
P2860
P304
P356
10.1155/2015/165105
P407
P5008
P577
2015-03-19T00:00:00Z